In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea
Open Access
- 31 December 2007
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 59 (4) , 473-475
- https://doi.org/10.1016/j.diagmicrobio.2007.07.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrheaAPMIS, 2007
- Changing Epidemiology of Shigellosis and Emergence of Ciprofloxacin-Resistant Shigellae in IndiaJournal of Clinical Microbiology, 2007
- Genetic characterization of multidrug resistance in Shigella spp. from JapanJournal of Medical Microbiology, 2006
- Ciprofloxacin-resistantSalmonellaKentucky in TravelersEmerging Infectious Diseases, 2006
- Prevention and Treatment of Traveler’s DiarrheaDigestion, 2006
- Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), IndiaEpidemiology and Infection, 2005
- Rifaximin in the Treatment of Infectious DiarrheaChemotherapy, 2005
- In Vitro Activity of Rifaximin against Enteropathogens Producing Traveler's DiarrheaAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activity and Fecal Concentration of Rifaximin after Oral AdministrationAntimicrobial Agents and Chemotherapy, 2000
- Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with travelers' diarrheaClinical Microbiology & Infection, 1998